Nuveen
TIL icon

Nuveen’s Instil Bio TIL Stock Holding History

Nuveen’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.89K Buy
+1,105
New +$8.2K ﹤0.01% 4589
2023
Q1 		– Sell
-941
Closed -$12K – 3138
2022
Q4 		$12K Sell
941
-10,658
-92% -$527K ﹤0.01% 3161
2022
Q3 		$1.12M Sell
11,599
-134
-1% -$15.3K ﹤0.01% 2695
2022
Q2 		$1.08M Buy
11,733
+2,283
+24% +$323K ﹤0.01% 2746
2022
Q1 		$2M Sell
9,450
-1,476
-14% -$345K ﹤0.01% 2506
2021
Q4 		$3.64M Buy
10,926
+8,065
+282% +$3.11M ﹤0.01% 2278
2021
Q3 		$1.13M Sell
2,861
-61
-2% -$22.8K ﹤0.01% 2949
2021
Q2 		$1.13M Buy
+2,922
New +$1.08M ﹤0.01% 2964

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $13.7M AUM 59.46% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Americana Partners
Americana Partners Houston, Texas $4.67B AUM 26.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
GK Wealth Management
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nuveen's TIL Position: Q3 2026 in Review

Nuveen opened a new position in Instil Bio (TIL) in Q3 2026: 1,105 shares worth $7.89K. The stake represents ﹤0.01% of the portfolio and ranks #4589 among its holdings. This is a return to the name: Nuveen previously reported a position in TIL as recently as Q4 2022.

Nuveen first reported a position in TIL in Q2 2021 and has held it in 8 quarters since. The position peaked at $3.64M in Q4 2021. 9 funds tracked by Wall St. Rank hold TIL as of Q3 2026.

  • Nuveen held 1,105 shares of Instil Bio worth $7.89K as of Q3 2026.
  • Instil Bio was a new Nuveen position in Q3 2026.
  • Instil Bio made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4589 holding.
  • Nuveen first reported a position in Instil Bio in Q2 2021 and has held it in 8 quarters since.
  • Nuveen's Instil Bio position peaked at $3.64M in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Instil Bio as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.